VP 16-213 IN ACUTE MYELOGENOUS LEUKEMIA

被引：51
|
作者：
SMITH, IE
GERKEN, ME
CLINK, HM
MCELWAIN, TJ
机构：
[1] INST CANC RES,LEUKAEMIA UNIT,SUTTON,ENGLAND
[2] ROY MARSDEN HOSP,SUTTON,SURREY,ENGLAND
来源：
POSTGRADUATE MEDICAL JOURNAL | 1976年 / 52卷 / 604期
关键词：
D O I：
10.1136/pgmj.52.604.66
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 70
页数：5
相关论文
共 50 条
  • [21] MITOXANTRONE AND VP-16 IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    HO, AD
    LIPP, T
    EHNINGER, G
    MEYER, P
    FREUND, M
    ILLIGER, HJ
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 121 - 121
  • [22] MITOXANTRONE AND VP-16 IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    HO, AD
    LIPP, T
    EHNINGER, G
    MEYER, P
    RUCKLE, H
    STEINKE, B
    KABOTH, W
    KORBLING, M
    ONKOLOGIE, 1986, 9 (03): : 148 - 150
  • [23] EPIPODOPHYLLOTOXIN (VP 16-213) IN DISSEMINATED HISTIOCYTIC LYMPHOMA - PILOT-STUDY
    JACOBS, P
    KING, H
    SEALY, R
    SOUTH AFRICAN MEDICAL JOURNAL, 1975, 49 (26): : 1056 - 1057
  • [24] DETERMINATION OF 2 HYDROPHYLIC METABOLITES OF THE ANTINEOPLASTIC AGENT ETOPOSIDE (VP 16-213)
    HOLTHUIS, JJM
    VANOORT, WJ
    HULSHOFF, A
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (06) : 289 - 289
  • [25] ANALYSIS AND DEGRADATION KINETICS OF ETOPOSIDE (VP 16-213) IN AQUEOUS-SOLUTION
    UNDERBERG, WJM
    KERKDIJK, HG
    HOLTHUIS, JJM
    BEIJNEN, JH
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (06) : 291 - 291
  • [26] CLINICAL EXPERIENCE WITH NEW EPIPODOPHYLLOTOXIN VP 16-213 IN TREATMENT OF HUMAN NEOPLASMS
    JUNGI, WF
    SENN, HJ
    BECKMANN, C
    FLURY, R
    FREI, P
    HOLDENER, E
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 105 (42) : 1365 - 1369
  • [27] VP 16-213 COMBINED WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND VINCRISTINE IN POLYCHEMOTHERAPY OF BRONCHOGENIC CARCINOMA
    RYSSEL, HJ
    HASLER, E
    SONNTAG, RW
    CAVALLI, F
    MARTIN, J
    TSCHOPP, L
    BRUNNER, KW
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1977, 107 (26) : 912 - 915
  • [28] ROLE OF METABOLIC-ACTIVATION IN THE ANTITUMOR ACTION OF ETOPOSIDE (VP 16-213)
    VANMAANEN, JMS
    DERUITER, C
    KOOTSTRA, PR
    BROERSEN, J
    DEVRIES, J
    LAFLEUR, MVM
    RETEL, J
    PINEDO, HM
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (06) : 300 - 300
  • [29] PILOT-STUDY TO DETERMINE AN INTERMITTENT DOSE SCHEDULE FOR VP 16-213
    EAGAN, RT
    AHMANN, DL
    HAHN, RG
    OCONNELL, MJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 55 - 55
  • [30] CHEMOTHERAPY OF SCLC WITH VP 16-213, CYCLOPHOSPHAMIDE AND DOXORUBICIN (VAC) OR METHOTREXATE (VMC)
    HAUSMANINGER, H
    SIMADER, H
    MLINERITSCH, B
    BLUT, 1986, 53 (03): : 140 - 140
12345